Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: Dexamethasone
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Prostate-Specific Antigen Levels and Prognosis in Patients with Hormone-Refractory Prostate Cancer Treated with Low-Dose Dexamethasone
Available to PurchaseSubject Area:
Further Areas
Masaaki Morioka, Tatsuya Kobayashi, Yoji Furukawa, Yoshimasa Jo, Masanori Shinkai, Takakazu Matsuki, Tokunori Yamamoto, Hiroyoshi Tanaka
Journal:
Urologia Internationalis
Urol Int (2002) 68 (1): 10–15.
Published Online: 09 January 2002
...Masaaki Morioka; Tatsuya Kobayashi; Yoji Furukawa; Yoshimasa Jo; Masanori Shinkai; Takakazu Matsuki; Tokunori Yamamoto; Hiroyoshi Tanaka Objective: The efficacy of low-dose dexamethasone (DXM) therapy in patients with hormone-refractory prostate cancer (HRPC) was evaluated. Patients and Methods...
Journal Articles
Hormonal Sensitivity following Endocrine Withdrawal in Hormone-Refractory Prostate Cancer
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2000) 65 (1): 28–31.
Published Online: 18 August 2000
... patients with refractory prostate cancer subsequent to primary combination hormonal therapy were enrolled in this study. All 16 patients with progressive disease after elimination of oral hormonal agents or after response following hormonal withdrawal received dexamethasone (DXM) (initially 1.5 or 1.0 mg...